TY - JOUR
T1 - Infantile idiopathic myopathic carnitine deficiency
T2 - Treatment with l-carnitine
AU - Shapira, Yehuda
AU - Glick, Benjamin
AU - Harel, Shaul
AU - Vattin, Jean Jacques
AU - Gutman, Alisa
PY - 1993
Y1 - 1993
N2 - A series of 9 infants, ranging in age from 3 months to 5 years (average: 2 years), suffered from idiopathic myopathic carnitine deficiency presenting as hypotonia and motor delay. Secondary carnitine deficiency was eliminated by appropriate tests. Muscle carnitine concentration ranged from 2.3-7.1 nmol/mg non-collagen protein (NCP; average: 4.87 nmol/mg NCP; normal: 22 ± 6 nmol/mg NCP). Lipid accumulation in muscle was observed in 2 of 8 patients. Therapy with l-carnitine (100 mg/kg/day in most patients) was given with clinical and laboratory follow-up 6 months later. In 7 of 9 patients, muscle tone and motor function improved. Muscle carnitine concentration increased to a range of 2.7-23.4 nmol/mg (average: 12.27 nmol/mg). In some patients the muscle carnitine content multiplied by a factor of 3-4, but carnitine concentration reached the normal range in only 2 patients. Most infants with idiopathic carnitine deficiency did benefit from 6 months of therapy; however, in order to achieve full recovery the duration of therapy should probably continue for longer periods, with a dose of not less than 100 mg/kg/day.
AB - A series of 9 infants, ranging in age from 3 months to 5 years (average: 2 years), suffered from idiopathic myopathic carnitine deficiency presenting as hypotonia and motor delay. Secondary carnitine deficiency was eliminated by appropriate tests. Muscle carnitine concentration ranged from 2.3-7.1 nmol/mg non-collagen protein (NCP; average: 4.87 nmol/mg NCP; normal: 22 ± 6 nmol/mg NCP). Lipid accumulation in muscle was observed in 2 of 8 patients. Therapy with l-carnitine (100 mg/kg/day in most patients) was given with clinical and laboratory follow-up 6 months later. In 7 of 9 patients, muscle tone and motor function improved. Muscle carnitine concentration increased to a range of 2.7-23.4 nmol/mg (average: 12.27 nmol/mg). In some patients the muscle carnitine content multiplied by a factor of 3-4, but carnitine concentration reached the normal range in only 2 patients. Most infants with idiopathic carnitine deficiency did benefit from 6 months of therapy; however, in order to achieve full recovery the duration of therapy should probably continue for longer periods, with a dose of not less than 100 mg/kg/day.
UR - http://www.scopus.com/inward/record.url?scp=0027399702&partnerID=8YFLogxK
U2 - 10.1016/0887-8994(93)90007-Y
DO - 10.1016/0887-8994(93)90007-Y
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0027399702
SN - 0887-8994
VL - 9
SP - 35
EP - 38
JO - Pediatric Neurology
JF - Pediatric Neurology
IS - 1
ER -